Viral
Hepatitis
- 0
FDA approves Merck & Co.’s Ebola vaccine Ervebo: January’s industry headlines
- 0
US FDA warns of serious liver injury linked to hepatitis C drugs: September’s industry headlines
Herpes
- 0
ASM Microbe: What consequences could lifelong Epstein–Barr virus infection have for the brain?
- 0
HR-HPV oral infection rates in England are lower than expected
- 0
A peek behind the paper – Lynn Enquist on the lifecycle of alpha herpesvirus
HIV / AIDS
- 0
Novel adjuvant helps extend immunity against HIV in primates
- 0
Do brain cells spread HIV to peripheral organs?
- 0
The London patient: long-term follow-up suggests no detectable HIV virus
HPV
- 0
FDA approves Merck & Co.’s Ebola vaccine Ervebo: January’s industry headlines
- 0
Could widespread HPV vaccination eliminate cervical cancer?
- 0
Understanding human papillomaviruses using organotypic 3D models – an interview with Sally Roberts
Influenza
- 0
Universal vaccines: A holy grail for the flu?
- 0
Could obesity promote virulence in influenza?
- 0
The lessons of flu blogging
Varicella Zoster
- 0
ECCMID18: Research suggests measles remains a ‘serious threat’ to those under two years old
- 0
Can social media trends predict population vaccinating behavior?
- 0
MMR vaccination: Pro-vaccination strategies fail to debunk popular misconceptions
West Nile
- 0
ECCMID18: Is West Nile virus re-emerging in Greece?
- 0
Malarial drug resistance and congenital complications – the week in infectious diseases
- 0
Could close relatives of the Zika virus also induce birth defects?
